Inventor
David Matthew Marquis
Inventor
Encinitas, CA, US
Overview
Patents· 33 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C07KPeptides27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07CAcyclic or carbocyclic compounds11%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%
C09KMaterials for miscellaneous applications, not provided for elsewhere2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
C07DHeterocyclic compounds1%
E21BEarth or rock drilling1%
PatentTitleYear
9,631,016'Pen-injector device containing anti-IL-6 antibodies'20179,340,613'Anti-IL-6 antibodies, compositions, methods and uses'20168,623,362'Anti-IL-6 antibodies'2014RE043672'Anti-IL-6 antibodies, compositions, methods and uses'20128,257,704'Anti-sclerostin antibodies'20128,226,611'Anti-IL-6 antibodies, compositions, methods and uses'20128,153,125'CD20 binding molecules'20128,128,927'Methods of using TGF-β 1 binding compositions'20128,067,003'Methods of treating conditions using anti-IL-6 antibodies'20118,003,102'Anti-CXCR4 antibodies'20117,988,970'Methods of treatment comprising administering an anti-sclerostin antibody'20117,901,679'Humanized anti-ghrelin antibodies'20117,892,546'Anti-CXCR4 antibodies'20117,872,102'Anti-IL-23 antibodies'20117,833,755'Anti-IL-6 antibody nucleic acid molecules and methods'20107,744,874'Anti-sclerostin antibodies'20107,619,069'Antibodies to TGF-beta 1'20097,560,112'Anti-il-6 antibodies, compositions, methods and uses'20097,479,271'Humanized anti-ghrelin antibodies'20097,435,799'TNF-α binding molecules'20087,101,978'TNF-α binding molecules'20066,858,210'Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same'20056,410,775'APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies'20026,207,160'aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies'20015,874,409'APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies'19995,363,915'Enhanced oil recovery technique employing nonionic surfactants'19945,076,357'Method of enhancing recovery of petroleum from an oil-bearing formation'19914,340,758'Nitration process for the preparation of 2,6-dialkylaniline'19824,259,246'Maleic anhydride production with recycle treatment'19814,231,943'Maleic anhydride production'19804,187,235'Method for preparing maleic anhydride'19804,132,670'Method of preparing vanadium (IV) phosphate composition with high intrinsic surface area'19794,071,540'Anhydride separation process'1978Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1978–1982Patents assigned to CHEVRON RES (6)· patent assignee history
1978–1994Based in Lafayette, CA, US· patent location history
1999–2017Based in Encinitas, CA, US· patent location history
2006–2017Patents assigned to APPLIED MOLECULAR EVOLUTION (10)· patent assignee history
2009–2012Patents assigned to LILLY CO ELI (10)· patent assignee history
2010–2014Patents assigned to MARQUIS DAVID MATTHEW (7)· patent assignee history
2010–2014Patents assigned to SMITH ERIC MICHAEL (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| APPLIED MOLECULAR EVOLUTION | 10 | 2006–2017 |
| LILLY CO ELI | 10 | 2009–2012 |
| MARQUIS DAVID MATTHEWself | 7 | 2010–2014 |
| CHEVRON RES | 6 | 1978–1982 |
| SMITH ERIC MICHAEL | 6 | 2010–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Encinitas, California, US | 25 | 1999–2017 |
| Lafayette, California, US | 8 | 1978–1994 |